Max Masucci
Stock Analyst at TD Cowen
(0.17)
# 3,155
Out of 4,413 analysts
27
Total ratings
19.05%
Success rate
-33.71%
Average return
Main Sectors:
17 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLFS BioLife Solutions | Maintains: Outperform | $29 → $25 | $17.48 | +43.02% | 1 | Aug 9, 2023 | |
| DMTK DermTech | Maintains: Outperform | $8 → $6 | $0.62 | +872.45% | 1 | Mar 29, 2023 | |
| GH Guardant Health | Maintains: Outperform | $70 → $53 | $18.26 | +190.25% | 1 | Feb 24, 2023 | |
| HOLX Hologic | Maintains: Outperform | $86 → $95 | $76.28 | +24.54% | 2 | Feb 2, 2023 | |
| QTRX Quanterix | Downgrades: Market Perform | $38 → $18 | $16.49 | +9.16% | 2 | Aug 9, 2022 | |
| BDSX Biodesix | Initiates: Outperform | n/a | $1.25 | - | 2 | Apr 20, 2022 | |
| EVO Evotec SE | Initiates: Outperform | n/a | $5.25 | - | 1 | Nov 29, 2021 | |
| NAUT Nautilus Biotechnology | Initiates: Outperform | n/a | $2.78 | - | 1 | Nov 2, 2021 | |
| MXCT MaxCyte | Initiates: Outperform | n/a | $3.78 | - | 1 | Aug 24, 2021 | |
| CTKB Cytek Biosciences | Initiates: Outperform | n/a | $6.37 | - | 1 | Aug 17, 2021 | |
| RPID Rapid Micro Biosystems | Initiates: Outperform | n/a | $0.93 | - | 1 | Aug 9, 2021 | |
| TKNO Alpha Teknova | Initiates: Outperform | n/a | $1.95 | - | 1 | Jul 20, 2021 | |
| AKYA Akoya Biosciences | Initiates: Buy | n/a | $3.96 | - | 1 | May 11, 2021 | |
| ILMN Illumina | Maintains: Buy | n/a | $124.68 | - | 3 | Apr 28, 2021 | |
| XGN Exagen | Initiates: Buy | n/a | $1.36 | - | 1 | Apr 15, 2021 | |
| TTOO T2 Biosystems | Maintains: Buy | $20,000 → $17,500 | $3.00 | +583,233.33% | 5 | Nov 5, 2020 | |
| EXAS Exact Sciences | Maintains: Buy | n/a | $60.01 | - | 2 | Oct 28, 2020 |
BioLife Solutions
Aug 9, 2023
Maintains: Outperform
Price Target: $29 → $25
Current: $17.48
Upside: +43.02%
DermTech
Mar 29, 2023
Maintains: Outperform
Price Target: $8 → $6
Current: $0.62
Upside: +872.45%
Guardant Health
Feb 24, 2023
Maintains: Outperform
Price Target: $70 → $53
Current: $18.26
Upside: +190.25%
Hologic
Feb 2, 2023
Maintains: Outperform
Price Target: $86 → $95
Current: $76.28
Upside: +24.54%
Quanterix
Aug 9, 2022
Downgrades: Market Perform
Price Target: $38 → $18
Current: $16.49
Upside: +9.16%
Biodesix
Apr 20, 2022
Initiates: Outperform
Price Target: n/a
Current: $1.25
Upside: -
Evotec SE
Nov 29, 2021
Initiates: Outperform
Price Target: n/a
Current: $5.25
Upside: -
Nautilus Biotechnology
Nov 2, 2021
Initiates: Outperform
Price Target: n/a
Current: $2.78
Upside: -
MaxCyte
Aug 24, 2021
Initiates: Outperform
Price Target: n/a
Current: $3.78
Upside: -
Cytek Biosciences
Aug 17, 2021
Initiates: Outperform
Price Target: n/a
Current: $6.37
Upside: -
Rapid Micro Biosystems
Aug 9, 2021
Initiates: Outperform
Price Target: n/a
Current: $0.93
Upside: -
Alpha Teknova
Jul 20, 2021
Initiates: Outperform
Price Target: n/a
Current: $1.95
Upside: -
Akoya Biosciences
May 11, 2021
Initiates: Buy
Price Target: n/a
Current: $3.96
Upside: -
Illumina
Apr 28, 2021
Maintains: Buy
Price Target: n/a
Current: $124.68
Upside: -
Exagen
Apr 15, 2021
Initiates: Buy
Price Target: n/a
Current: $1.36
Upside: -
T2 Biosystems
Nov 5, 2020
Maintains: Buy
Price Target: $20,000 → $17,500
Current: $3.00
Upside: +583,233.33%
Exact Sciences
Oct 28, 2020
Maintains: Buy
Price Target: n/a
Current: $60.01
Upside: -